Clinical Trials Directory

Trials / Completed

CompletedNCT05721040

Short-term Evaluation of Motor and Sensory Function in Post-COVID-19 Patients

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
20 Years – 68 Years
Healthy volunteers
Accepted

Summary

SARS-COV-2 infection reframed medical knowledge in many aspects, yet there is still a lot to be discovered. our aim is to evaluate neurological impact of covid-19; if there is any.

Detailed description

Coronavirus disease 19 (COVID-19) can cause neuropsychiatric, psychological and psychosocial impairments. Literature regarding the sensory and motor affection of COVID-19 is still limited. Public health emergencies as COVID-19 are likely to cause adverse neuropsychiatric impacts. Cognitive impairments after SARS-COV-2 infection were noticed, COVID-19 patients complain of poor concentration, declined memory, and insomnia, as well as anxiety and depression symptoms. in a study; Neurological manifestations described in 36.4% of 214 patients with confirmed COVID-19. However, the symptoms described \[dizziness (not further defined), headache, and impaired consciousness\] are commonplace in many severe infections and represent disturbances in neurological function rather than a neurological disease per se. Anosmia and ageusia have received much attention, but are ubiquitous in other common upper respiratory tract infections. While a reported increased risk of cerebrovascular disease.

Conditions

Timeline

Start date
2021-10-01
Primary completion
2022-04-01
Completion
2022-09-01
First posted
2023-02-09
Last updated
2023-02-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05721040. Inclusion in this directory is not an endorsement.